Brief: Novocure’s PANOVA-3 Quality of Life, Pain Data Published in JAMA Network Open
BRIEF-Novocure’s PANOVA-3 Quality of Life, Pain Data Published in JAMA Network Open Nov 13 (Reuters) - NovoCure Limited NVCR.O:
JAMA NETWORK OPEN PUBLISHES QUALITY OF LIFE AND PAIN OUTCOMES DATA FROM PHASE 3 PANOVA-3 TRIAL OF NOVOCURE’S TUMOR TREATING FIELDS FOR PANCREATIC CANCER
Source text: ID:nBw6PYj59a
Further company coverage: NVCR.O
(Reporting by Zakia Mariyam)
((Zakia.Mariyam@thomsonreuters.com;))
Recent news on NovoCure
See all newsBrief: Novocure’s PANOVA-3 Quality of Life, Pain Data Published in JAMA Network Open
US FDA declines to approve Novocure's lung cancer device
Brief: Novocure Provides FDA Update on Optune Mya Approval Application for Lung Cancer Brain Metastases
NovoCure Limited reports results for the quarter ended September 30 - Earnings Summary
Switzerland's Novocure Q3 revenue rises 16%, beats estimates